Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
14.40
-0.03 (-0.21%)
At close: Sep 14, 2026, 4:00 PM EDT
14.41
+0.01 (0.07%)
After-hours: Sep 14, 2026, 7:30 PM EDT
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $1.33 billion as of September 14, 2026. Its market cap has increased by 310.35% in one year.
Market Cap
1.33B
Enterprise Value
1.24B
1-Year Change
310.35%
Ranking
Category
Stock Price
$14.40
ChartMarket Cap Chart
Since March 8, 2021, Alpha Tau Medical's market cap has increased from $347.19M to $1.33B, an increase of 282.96%. That is a compound annual growth rate of 27.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 1.33B | 215.03% |
| Dec 31, 2025 | 422.06M | 94.21% |
| Dec 31, 2024 | 217.32M | 3.92% |
| Dec 29, 2023 | 209.12M | -4.71% |
| Dec 30, 2022 | 219.46M | -34.99% |
| Dec 31, 2021 | 337.56M | -2.77% |
| Mar 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Absci | 1.41B |
| Ultragenyx Pharmaceutical | 1.41B |
| Maze Therapeutics | 1.37B |
| Savara | 1.35B |
| Cullinan Therapeutics | 1.33B |
| Omeros | 1.32B |
| Vor Biopharma | 1.32B |
| Tyra Biosciences | 1.31B |